Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$781M |
| 2 |
Amazon
AMZN
|
+$728M |
| 3 |
AABA
Altaba Inc
AABA
|
+$535M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$296M |
| 5 |
Booking.com
BKNG
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$353M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$261M |
| 3 |
Alibaba
BABA
|
+$228M |
| 4 |
Citigroup
C
|
+$170M |
| 5 |
DuPont de Nemours
DD
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.47% |
| 2 | Technology | 2.03% |
| 3 | Consumer Discretionary | 1.46% |
| 4 | Financials | 1.01% |
| 5 | Healthcare | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SORL
7876
PUT
DELISTED
SORL Auto Parts, Inc.
SORL
| $251K | ﹤0.01% |
37,600
+17,500
| +87% | +$104K |
|
7877
Citi Trends
CTRN
$572M
| $250K | ﹤0.01% |
11,778
-551
| -4% | -$10.4K |
|
7878
WisdomTree International Equity Fund
DWM
$691M
| $250K | ﹤0.01% |
4,815
-8,876
| -65% | -$458K |
|
7879
CALL
Frontline
FRO
$9.74B
| $250K | ﹤0.01% |
43,600
-62,700
| -59% | -$385K |
|
7880
CALL
Selective Insurance
SIGI
$5.5B
| $250K | ﹤0.01% |
+5,000
| New | +$247K |
|
|
THR
7881
DELISTED
Thermon Group Holdings
THR
| $250K | ﹤0.01% |
13,062
-27,819
| -68% | -$546K |
|
|
RIC
7882
PUT
DELISTED
Richmont Mines Inc.
RIC
| $250K | ﹤0.01% |
32,000
-2,200
| -6% | -$16.4K |
|
7883
Banco de Chile
BCH
$21B
| $249K | ﹤0.01% |
10,076
| – | – |
|
7884
PUT
Eversource Energy
ES
$26.7B
| $249K | ﹤0.01% |
4,100
-3,400
| -45% | -$206K |
|
7885
CALL
Korn Ferry
KFY
$4.35B
| $249K | ﹤0.01% |
7,200
-6,800
| -49% | -$221K |
|
7886
CALL
Noodles & Co
NDLS
$88.1M
| $249K | ﹤0.01% |
7,988
-100
| -1% | -$3.9K |
|
7887
PUT
Schwab U.S Small- Cap ETF
SCHA
$23B
| $249K | ﹤0.01% |
15,600
-10,800
| -41% | -$171K |
|
|
TPHS
7888
DELISTED
Trinity Place Holdings Inc.com
TPHS
| $249K | ﹤0.01% |
+35,021
| New | +$249K |
|
|
CVO
7889
CALL
DELISTED
Cenevo, Inc.
CVO
| $249K | ﹤0.01% |
40,900
+9,600
| +31% | +$50.1K |
|
|
ELOS
7890
CALL
DELISTED
Syneron Medical Ltd
ELOS
| $249K | ﹤0.01% |
22,700
-4,400
| -16% | -$48.2K |
|
7891
iShares Core Moderate Allocation ETF
AOM
$1.79B
| $248K | ﹤0.01% |
6,661
-24,559
| -79% | -$907K |
|
7892
First Trust Health Care AlphaDEX Fund
FXH
$1.16B
| $248K | ﹤0.01% |
3,703
-4,572
| -55% | -$294K |
|
7893
PUT
Galectin Therapeutics
GALT
$418M
| $248K | ﹤0.01% |
100,800
+81,400
| +420% | +$217K |
|
7894
CALL
HEICO Corp
HEI
$47.1B
| $248K | ﹤0.01% |
6,738
-11,328
| -63% | -$417K |
|
7895
CALL
Identive
INVE
$68.1M
| $248K | ﹤0.01% |
47,300
+400
| +0.9% | +$2.28K |
|
7896
Karyopharm Therapeutics
KPTI
$44M
| $248K | ﹤0.01% |
1,827
+95
| +5% | +$14.1K |
|
7897
S&T Bancorp
STBA
$1.76B
| $248K | ﹤0.01% |
+6,913
| New | +$242K |
|
7898
Twilio
TWLO
$37.1B
| $248K | ﹤0.01% |
8,515
-408,765
| -98% | -$11.2M |
|
|
CSII
7899
CALL
DELISTED
Cardiovascular Systems, Inc.
CSII
| $248K | ﹤0.01% |
7,700
+500
| +7% | +$15.2K |
|
|
ASA
7900
CALL
ASA Gold and Precious Metals
ASA
$1.23B
| $247K | ﹤0.01% |
21,100
+1,100
| +6% | +$13.2K |
|
Similar funds
Jeff Yass's Q2 2017 Portfolio in Review
As of Q2 2017, Jeff Yass held 10,525 positions worth $228B, up 15% from $198B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass's Q2 2017 filing shows 1,702 new, 3,804 increased, 3,457 reduced and 1,419 closed positions. Its largest new stake was Altaba Inc: 9,835,232 shares worth $536M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $353M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2017 buy was Altaba Inc: 9,835,232 shares worth $536M.
- Jeff Yass added most to Apple in Q2 2017, an estimated $781M increase.
- Jeff Yass's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $353M.
- Jeff Yass fully exited Alphabet (Google) Class C in Q2 2017, selling an estimated $261M.
- Jeff Yass's ten largest holdings make up 22% of its $228B portfolio in Q2 2017.
- Jeff Yass opened 1,702 new positions and closed 1,419 in Q2 2017.
- Jeff Yass's portfolio value rose 15% quarter-over-quarter to $228B.
Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.